Loading insider details...
Latest Form 4 (Nov 13, 2026): Sale of 158,194 ROIV shares, $6.40M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 13, 2026 | Roivant Sciences Ltd. (ROIV) | Sale | 158,194 | $6.40M |
| Nov 5, 2026 | Roivant Sciences Ltd. (ROIV) | Sale | 200,000 | $7.26M |
| Oct 30, 2026 | Roivant Sciences Ltd. (ROIV) | Sale | 200,000 | $7.32M |
| Oct 22, 2026 | Roivant Sciences Ltd. (ROIV) | Sale | 185,856 | $6.52M |
| Oct 5, 2026 | Immunovant, Inc. (IMVT) | Exercise/Conversion | 92,187 | $1.33M |
| Oct 2, 2026 | Roivant Sciences Ltd. (ROIV) | Exercise/Conversion | 200,000 | $770.0K |
| Sep 2, 2026 | Roivant Sciences Ltd. (ROIV) | Exercise/Conversion | 200,000 | $770.0K |
| Aug 25, 2026 | Roivant Sciences Ltd. (ROIV) | Tax Withholding | 13,909 | $512.4K |
| Jul 30, 2026 | Roivant Sciences Ltd. (ROIV) | Exercise/Conversion | 200,000 | $770.0K |
| Jul 6, 2026 | Immunovant, Inc. (IMVT) | Exercise/Conversion | 92,188 | $1.33M |